James Flexner

James Flexner is the current director at Saol Therapeutics. James has over seven years of experience working in the finance industry. Prior to joining Saol Therapeutics, they worked as an associate at Metalmark Capital for three years and as an investment banking analyst at Morgan Stanley for two years. James has a degree in finance from the University of Pennsylvania.

James Flexner went to Dartmouth College and graduated with a Bachelor of Arts.